global Intravenous solution The market size is estimated at USD 11.3 billion in 2021 and expected to grow at a CAGR. 7.7% Between 2023-2032.
Patients are given intravenous solutions when oral intake of water and food is not possible due to various medical disorders or organ failure.
The increasing number of patients with end-stage renal disease (ESRD), oral cancer, esophageal cancer, and other related medical problems is driving the market for intravenous therapy. Since patients cannot consume food or water while being treated for these conditions, nutrition is given to patients via intravenous solutions.
Access sample reports: https://www.insightslice.com/request-sample/308
With a base year of 2021 and a forecast period of 2022-2032, the study titled Intravenous Solutions Market provides analysis, trends and forecasts of global market share.
The competitive landscape is also taken into consideration in the report, providing company profiles and market forecasts for top companies in the Intravenous Solutions market.
In addition, the study analyzes all major market participants’ significant developments, global and regional sales networks, corporate strategies, security and exchange overviews, R&D activities, manufacturing facilities, market position, staff strength, and Analysis of key executives is provided.
Major Players in the Global Intravenous Solutions Market are:
Axa Parenterals Ltd., Amanta Healthcare, Baxter International Inc., B. Braun Melsungen Ag, Grifols, SA, Fresenius Kabi USA, LLC, JW Life Science, ICU Medical, Inc., Vifor Pharma Management Ltd., and Salius Pharma Private Limited are some of the strong market stakeholders in the global intravenous solutions market.
What is covered in the intravenous solutions report?
The study takes into account key competitive data including company strategies, product portfolios, key developments, SWOT analysis, and development and research objectives of all Intravenous Solutions companies.
Additionally, market shares of well-known companies operating in the global Intravenous Solutions market are calculated. For example, B. Braun Melsungen Ag said that in 2018 he had revenue of US$746.24 million.
The B. Braun Hospital Care business unit accounted for the majority of the company’s revenue in 2018, according to the company’s sector and geographic assessment, with Germany and North America being the two main revenue-generating regions.
The four business divisions of B. Braun Melsungen Ag are: B. Braun Aesculap, B. Braun OPM, B. Braun Avitum, and B. Braun Hospital Care. His B. Braun Avitum business segment of the company generated his US$116.88 million revenue in 2018 and provides intravenous solutions in the global market.
For more information on the content of the report, please visit https://www.insightslice.com/intravenous-solutions-market.
The study also analyzes company strategies, product offerings, advancements, SWOT analysis, and key competitive data including all IV manufacturing companies worldwide.
Participants involved in the distribution chain and value network of the market, and their contributions, are considered by the global intravenous solutions market analysis. The product portfolio includes all products in the company’s Infusion Solutions Markets business unit.
Similarly, the Recent Developments section focuses on the latest activities of companies such as mergers and acquisitions, strategic alliances and collaborations, new product launches, and geographic expansion of the IV Solutions industry.
What are the regional growth forecasts for the global infusion solutions market?
The market is segmented according to location into North America, Europe, Asia Pacific, Middle East & Africa, and South America. In the United States, he had more than half a million people on dialysis in 2016, and the National Kidney Foundation estimates that 15% of adult Americans have chronic kidney problems. increase.
Due to the increasing number of renal failure patients internationally, the need for intravenous solutions is expected to increase in the coming years.
Due to the increase in the elderly population and the improvement of medical services, the average life expectancy of the elderly population is also increasing. Asia-Pacific is therefore expected to witness the largest growth during the forecast period.
Related reports:
Global Subcutaneous Drug Delivery Device Market: https://www.insightslice.com/subcutaneous-drug-delivery-device-market
Global Legal Marijuana Market: https://www.insightslice.com/legal-marijuana-market
Key Segments of the Global Intravenous Solutions Market:
Based on solution type
- saline
- Dextran
- lactated ringer
- amino acid
- vitamins and minerals
- Heparin and trace elements
- mixed solution
Based on bag capacity
- Small volume bag (less than 250ml)
- Large capacity bag (250ml or more)
based on application
- basic drip
- nutrition drip
- blood drip
- drug drip
- Irrigation intravenous solution
based on end user
- hospital
- Clinic
- Ambulatory Surgery Center
- home care settings
By Geography:
- North America
- America
- Canada
- Rest of North America
- Europe
- Germany
- England
- Italy
- France
- Spain
- rest of europe
- Asia Pacific
- Japan
- India
- China
- Australia
- Rest of Asia Pacific
- Middle East and Africa
- United Arab Emirates
- Saudi Arabia
- South Africa
- Middle East and rest of Africa
- South America
- Brazil
- Rest of South America
Proceed to purchase: https://www.insightslice.com/buy-now/308
Insight SLICE is a market intelligence and strategy consulting firm. The company offers bespoke commercial market research studies. The company’s primary focus is strategy consulting to deliver end-to-end solutions. For more information, please contact our research and consulting team. info@insightslice.com.
inquiry:
Alex R.
+1 707 736 6633
alex@insightslice.com
https://www.insightslice.com/
link in | | twitter
